Core Scientific, Inc.
CORZ
$16.42
-$0.55-3.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 150.23% | -13.05% | -46.63% | -57.91% | -49.51% |
| Total Other Revenue | -47.23% | -15.70% | -43.63% | -55.20% | -28.77% |
| Total Revenue | -15.97% | -14.95% | -44.28% | -55.64% | -33.12% |
| Cost of Revenue | -44.15% | -19.17% | -28.04% | -29.84% | -24.06% |
| Gross Profit | 113.28% | 2,603.21% | -87.05% | -89.42% | -56.76% |
| SG&A Expenses | -11.66% | 58.24% | 81.44% | 137.03% | 49.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1,631.30% | -5,418.93% | -5,202.23% | 2,068.32% | -9.25% |
| Total Operating Expenses | 15.20% | -4.39% | -24.96% | 3.46% | -9.50% |
| Operating Income | -118.47% | -20.33% | -422.89% | -169.52% | -633.05% |
| Income Before Tax | 155.21% | 67.80% | -16.39% | 175.44% | -98.63% |
| Income Tax Expenses | -74.67% | -6.72% | 9.72% | -0.49% | 11.61% |
| Earnings from Continuing Operations | 155.14% | 67.79% | -16.39% | 175.61% | -98.48% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 155.14% | 67.79% | -16.39% | 175.61% | -98.48% |
| EBIT | -118.47% | -20.33% | -422.89% | -169.52% | -633.05% |
| EBITDA | -1,754.40% | -171.70% | -109.25% | -125.33% | -107.15% |
| EPS Basic | 158.76% | 60.57% | 81.29% | -118.69% | -97.74% |
| Normalized Basic EPS | 201.66% | 75.11% | 35.09% | 327.74% | -285.71% |
| EPS Diluted | 140.47% | 60.57% | 81.21% | -121.99% | -96.08% |
| Normalized Diluted EPS | 169.92% | 75.11% | 35.09% | 423.35% | -285.71% |
| Average Basic Shares Outstanding | 4.40% | 8.92% | 78.14% | 36.48% | -20.50% |
| Average Diluted Shares Outstanding | 51.75% | 8.92% | 78.14% | 11.56% | -20.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |